Literature DB >> 35582327

Adjuvant Therapy System of COVID-19 Patient: Integrating Warning, Therapy, Post-Therapy Psychological Intervention.

Miao Li1, Yixue Hao1, Yaxiong Ma1, Jincai Chen1, Long Hu1, Min Chen1, Kai Hwang2,3, Zhongchun Liu4.   

Abstract

The 2019 novel coronavirus(COVID-19) spreads rapidly, and the large-scale infection leads to the lack of medical resources. For the purpose of providing more reasonable medical service to COVID-19 patients, we designed an novel adjuvant therapy system integrating warning, therapy, and post-therapy psychological intervention. The system combines data analysis, communication networks and artificial intelligence(AI) to design a guidance framework for the treatment of COVID-19 patients. Specifically, in this system, we first can use blood characteristic data to help make a definite diagnosis and classify the patients. Then, the classification results, together with the blood characteristics and underlying diseases disease characteristics of the patient, can be used to assist the doctor in treat treating the patient according to AI algorithms. Moreover, after the patient is discharged from the hospital, the system can monitor the psychological and physiological state at the data collection layer. And in the data feedback layer, this system can analyze the data and report the abnormalities of the patient to the doctor through communication network. Experiments show the effectiveness of our proposed system.

Entities:  

Keywords:  5G communication; COVID-19; adjuvant therapy system; blood characteristic

Year:  2021        PMID: 35582327      PMCID: PMC8905612          DOI: 10.1109/TNSE.2021.3077280

Source DB:  PubMed          Journal:  IEEE Trans Netw Sci Eng        ISSN: 2327-4697


  22 in total

1.  [Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].

Authors:  Y X Li; W Wu; T Yang; W Zhou; Y M Fu; Q M Feng; J M Ye
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2020-03-01

2.  High rates of 30-day mortality in patients with cirrhosis and COVID-19.

Authors:  Massimo Iavarone; Roberta D'Ambrosio; Alessandro Soria; Michela Triolo; Nicola Pugliese; Paolo Del Poggio; Giovanni Perricone; Sara Massironi; Angiola Spinetti; Elisabetta Buscarini; Mauro Viganò; Canio Carriero; Stefano Fagiuoli; Alessio Aghemo; Luca S Belli; Martina Lucà; Marianna Pedaci; Alessandro Rimondi; Maria Grazia Rumi; Pietro Invernizzi; Paolo Bonfanti; Pietro Lampertico
Journal:  J Hepatol       Date:  2020-06-09       Impact factor: 25.083

3.  Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis.

Authors:  Ashish Kumar; Anil Arora; Praveen Sharma; Shrihari Anil Anikhindi; Naresh Bansal; Vikas Singla; Shivam Khare; Abhishyant Srivastava
Journal:  Diabetes Metab Syndr       Date:  2020-05-06

4.  Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19.

Authors:  Poramed Winichakoon; Romanee Chaiwarith; Chalerm Liwsrisakun; Parichat Salee; Aree Goonna; Atikun Limsukon; Quanhathai Kaewpoowat
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

Review 5.  Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.

Authors:  Arun Samidurai; Anindita Das
Journal:  Int J Mol Sci       Date:  2020-09-16       Impact factor: 5.923

6.  Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases.

Authors:  Wei Huang; Chenze Li; Zhiquan Wang; Hong Wang; Ning Zhou; Jiangang Jiang; Li Ni; Xin A Zhang; Dao-Wen Wang
Journal:  Sci China Life Sci       Date:  2020-06-18       Impact factor: 10.372

7.  Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.

Authors:  Mario Gennaro Mazza; Rebecca De Lorenzo; Caterina Conte; Sara Poletti; Benedetta Vai; Irene Bollettini; Elisa Maria Teresa Melloni; Roberto Furlan; Fabio Ciceri; Patrizia Rovere-Querini; Francesco Benedetti
Journal:  Brain Behav Immun       Date:  2020-07-30       Impact factor: 7.217

8.  Factors associated with COVID-19-related death using OpenSAFELY.

Authors:  Elizabeth J Williamson; Alex J Walker; Krishnan Bhaskaran; Seb Bacon; Chris Bates; Caroline E Morton; Helen J Curtis; Amir Mehrkar; David Evans; Peter Inglesby; Jonathan Cockburn; Helen I McDonald; Brian MacKenna; Laurie Tomlinson; Ian J Douglas; Christopher T Rentsch; Rohini Mathur; Angel Y S Wong; Richard Grieve; David Harrison; Harriet Forbes; Anna Schultze; Richard Croker; John Parry; Frank Hester; Sam Harper; Rafael Perera; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

9.  High-resolution CT features in patients with COVID-19 pneumonia and negative nasopharyngeal and oropharyngeal swabs.

Authors:  Emilio Quaia; Elisa Baratella; Filippo Crimi; Luca Cancian; Paola Crivelli; Andrea Vianello
Journal:  Pulmonology       Date:  2020-10-21

10.  Risk factors for death in 1859 subjects with COVID-19.

Authors:  Lei Chen; Jianming Yu; Wenjuan He; Li Chen; Guolin Yuan; Fang Dong; Wenlan Chen; Yulin Cao; Jingyan Yang; Liling Cai; Di Wu; Qijie Ran; Lei Li; Qiaomei Liu; Wenxiang Ren; Fei Gao; Hongxiang Wang; Zhichao Chen; Robert Peter Gale; Qiubai Li; Yu Hu
Journal:  Leukemia       Date:  2020-06-16       Impact factor: 12.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.